Plans to build a new research centre in neural circuits and behaviour at UCL have been granted planning permission. Plans were approved by London Borough of Camden, subject to referral to the Mayor.
CBRC-supported researchers are part of an international consortium which is one step closer to understanding the genes associated with progressive supranuclear palsy (PSP), according to a study published in Nature Genetics.
Seminal works by UCL neuroscientists including CBRC-supported researchers account for 10 out of the top 100 most cited Parkinson’s disease researchers, according to a list published in the Journal of Parkinson’s Disease.
CBRC-funded projects have been showcased by the European Union for their work on antimicrobial drug resistance (AMR). The EU has been strongly committed to combating AMR for over 10 years and has prioritised research in this field. Projects showcased include two CBRC-supported projects at UCL: the
The CBRC received a fantastic response to the funding call made in autumn 2010. After a robust peer review process, grants were awarded to projects from the infectious disease, neurotherapeutics, neurodiagnostics and cardiovascular disease themes.
Joint funding by the CBRC and University College London Hospital (UCLH) has enabled UCLH to install an advanced scanner specifically for translational research.
Researchers in the CBRC’s oral health theme have found that insufficient cleaning could allow build-up of potentially pathogenic microbes on orthodontic retainers.
Initial treatment for HIV is three times more likely to fail if a person is infected with transmitted drug resistant (TDR) HIV compared to non-resistant HIV, according to a European-wide study involving CBRC and UCL investigators.
CBRC investigator Professor Derek Yellon is one of 23 eminent researchers to be honoured with the status of National Institute of Health Research (NIHR) Senior Investigator in the latest round of NIHR appointments.
We are holding a series of seminars on 7 March to showcase the best of activities. This is in support of the development of a new Bloomsbury Institute of Pathogen Research which is nearing completion.
